Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 Jan;36(1):149-156.
doi: 10.1111/jce.16490. Epub 2024 Nov 7.

Unipolar Voltage for Better Characterizing Left Atrium Substrates: Comparing the Predictive Efficacy for Recurrence Post Atrial Fibrillation Ablation in a Post Hoc Analysis of STABLE-SR-III Trial

Xiuyu Qi  1 , Hongwu Chen  1 , Gang Yang  1 , Hailei Liu  1 , Zidun Wang  1 , Xiaohong Jiang  1 , Chang Cui  1 , Cheng Cai  1 , Weizhu Ju  1 , Minglong Chen  1
Affiliations
Randomized Controlled Trial

Unipolar Voltage for Better Characterizing Left Atrium Substrates: Comparing the Predictive Efficacy for Recurrence Post Atrial Fibrillation Ablation in a Post Hoc Analysis of STABLE-SR-III Trial

Xiuyu Qi et al. J Cardiovasc Electrophysiol. 2025 Jan.

Abstract

Background: While bipolar voltage (BV) is acknowledged as an indicator of viable cardiomyocyte activation, unipolar recording has emerged as an alternative technique due to its advantage of providing a wider field of view. This study aims to compare the efficacy of unipolar voltage (UV) versus BV in predicting ablation recurrence in atrial fibrillation patients.

Methods: In Substrate Ablation in the Left Atrium during Sinus Rhythm Trial III, 375 patients completed the follow-up with preserved mapping data were included in the analysis. For each patient, the mean UV and BV was obtained from the electrograms sampled in left atrium (LA).

Results: Totally 301 patients experience the primary endpoint within 23.0 ± 9.2 months. While both low UV and BV had significant associations with long-term recurrence of atrial tachyarrhythmia (ATa), only mean UV was independently associated with the outcome. The model by UV with ablation feature had higher discriminatory power to predict ATa recurrence compared with BV model (area under the curve [AUC]: 0.858 vs. 0.757, p < 0.001). In subgroup analysis, UV reveals more powerful predictive efficacy compared with BV, with the AUC 0.843 versus 0.751 (p < 0.001) in circumferential pulmonary vein isolation (CPVI) alone cohort and 0.882 versus 0.750 (p < 0.001) in CPVI plus cohort, respectively.

Conclusion: UV exhibits higher efficacy for predicting long-term ATa recurrence after ablation compared with BV in elderly patients with atrial fibrillation regardless of whether the patient accepts substrate modification. The outcome suggests that unipolar recording may better characterize LA fibrosis by capturing more comprehensive transmural features than bipolar signals.

Clinical trial registration: ClinicalTrials.gov; URL: https://www.

Clinicaltrials: gov. Unique Identifier: NCT03462628.

Keywords: atrial fibrillation; atrial substrate; catheter ablation; unipolar voltage mapping.

PubMed Disclaimer

References

    1. B. J. J. M. Brundel, X. Ai, M. T. Hills, M. F. Kuipers, G. Y. H. Lip, and N. M. S. de Groot, “Atrial Fibrillation,” Nature Reviews Disease Primers 8, no. 1 (2022): 21.
    1. C. Sohns and N. F. Marrouche, “Atrial Fibrillation and Cardiac Fibrosis,” European Heart Journal 41, no. 10 (2020): 1123–1131.
    1. S. Nattel, “Molecular and Cellular Mechanisms of Atrial Fibrosis in Atrial Fibrillation,” JACC: Clinical Electrophysiology 3, no. 5 (2017): 425–435.
    1. A. Xintarakou, S. Tzeis, S. Psarras, D. Asvestas, and P. Vardas, “Atrial Fibrosis as a Dominant Factor for the Development of Atrial Fibrillation: Facts and Gaps,” EP Europace 22, no. 3 (2020): 342–351.
    1. B. Yang, C. Jiang, Y. Lin, et al., “STABLE‐SR (Electrophysiological Substrate Ablation in the Left Atrium During Sinus Rhythm) for the Treatment of Nonparoxysmal Atrial Fibrillation: A Prospective, Multicenter Randomized Clinical Trial,” Circulation: Arrhythmia and Electrophysiology 10, no. 11 (2017): e005405.

Publication types

MeSH terms

Associated data